Clicky

Genprex, Inc.(GNPX) News

Date Title
Jun 24 Genprex Collaborators Present Positive Preclinical Research on Diabetes Gene Therapy at the 2025 American Diabetes Association 85th Scientific Sessions
Jun 23 Genprex Collaborators Present Research on Non-Viral Approach to Diabetes Gene Therapy Using Lipid Nanoparticle Delivery System at the 2025 American Diabetes Association 85th Scientific Sessions
Feb 19 Genprex Advances Diabetes Program with Addition of Research Focused on Non-Viral Delivery System
Feb 18 Genprex Provides Update on Diabetes Gene Therapy Program
Oct 10 Genprex Collaborators to Present Positive Preclinical Data on the Use of Reqorsa® Gene Therapy at the 2024 EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics
Oct 7 Genprex Collaborators to Present Positive Preclinical Data on Reqorsa® Gene Therapy at the Society for Immunotherapy of Cancer 2024 Annual Meeting
Sep 4 Genprex Announces Plans to Launch Separate Company to Focus on the Development of Gene Therapy to Treat Type-1 and Type-2 Diabetes
Sep 3 Genprex to Present and Participate at Upcoming September Investor and Industry Conferences
May 15 Genprex dosing subjects in trial of combination therapy for small-cell lung cancer
May 14 Genprex Doses First Patient in Acclaim-3 Clinical Study of Reqorsa® Immunogene Therapy in Combination with Tecentriq® to Treat Small Cell Lung Cancer
May 13 Genprex Announces the Appointment of Jose A. Moreno Toscano as Chairman of the Board of Directors
May 8 Genprex Announces the Passing of its Co-Founder and Chief Executive Officer, Rodney Varner
May 7 Sidoti Events, LLC's Virtual May Micro-Cap Conference
May 1 Genprex to Present and Participate at Upcoming May Investor and Industry Conferences
Apr 9 Genprex Collaborators Report Positive Preclinical Data on the Use of Reqorsa® and on NPRL2 Gene Therapy Utilizing Non-Viral Oncoprex® Delivery System for the Treatment of Lung Cancers at the 2024 AACR Annual Meeting
Apr 4 Genprex (GNPX) Expands SCLC Study of Key Candidate, Stock Up
Apr 3 Genprex Expands Clinical Trial Sites for Acclaim-3 Clinical Study of Reqorsa® Therapy in Combination with Tecentriq® to Treat Small Cell Lung Cancer
Apr 2 Genprex Collaborators Publish Positive Preclinical Data with NPRL2 Gene Therapy Utilizing Oncoprex® Delivery System
Mar 22 Genprex Announces Closing of $6.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
Mar 19 Genprex Announces $6.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules